Loading...
15 years journey of idiopathic pulmonary arterial hypertension with BMPR2 mutation
Pulmonary arterial hypertension (PAH) is known as one of diseases with the worst prognosis. Recently, targeted PAH drugs have been developed and approved for use; therefore, the treatment strategy and goals have changed, and the prognosis has improved over two decades. We reviewed the case of a fema...
Saved in:
| Published in: | Clin Hypertens |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6771102/ https://ncbi.nlm.nih.gov/pubmed/31583114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40885-019-0127-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|